ICAM-3 endows anticancer drug resistance against microtubule-damaging agents via activation of the ICAM-3-AKT/ERK-CREB-2 pathway and blockage of apoptosis-Reference-Cited by-同舟云学术

ICAM-3 endows anticancer drug resistance against microtubule-damaging agents via activation of the ICAM-3-AKT/ERK-CREB-2 pathway and blockage of apoptosis

Published:2013-11 Issue:2 Volume:441 Page:507-513
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Ahn Kwang-Chul,Choi Jae Yeon,Kim Jae-Sung,Hwang Sang-Gu,Kim Wun-Jae,Park Jong Kuk,Um Hong-Duck

Funder

National Research Foundation of Korea (NRF)

Korean Government (MEST)

Basic Science Research Program

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference31 articles.

1. Increased expression of ICAM-3 is associated with radiation resistance in cervical cancer;Chung;Int. J. Cancer,2005

2. Classification of anticancer drugs – a new system based on therapeutic targets;Espinosa;Cancer Treat. Rev.,2003

3. Molecular aspects of cancer cell resistance to chemotherapy;Rebucci;Biochem. Pharmacol.,2013

4. Microtubules as a target for anticancer drugs;Jordan;Nat. Rev. Cancer,2004

5. P-glycoprotein: from genomics to mechanism;Ambudkar;Oncogene,2003

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ICAMs in Immunity, Intercellular Adhesion and Communication;Cells;2024-02-14

2. Functional evaluation of various ICAM3 transcript variants in diffuse large B-Cell lymphoma;Leukemia & Lymphoma;2022-07-18

3. Epigenetic inhibition of the tumor suppressor ARHI by light at night‐induced circadian melatonin disruption mediates STAT3‐driven paclitaxel resistance in breast cancer;Journal of Pineal Research;2019-06-09

4. Isoforms S and L of MRPL33 from alternative splicing have isoform‑specific roles in the chemoresponse to epirubicin in gastric cancer cells via the PI3K/AKT signaling pathway;International Journal of Oncology;2019-02-27

5. ICAM3 mediates inflammatory signaling to promote cancer cell stemness;Cancer Letters;2018-05